News

Public · Published

Intel to buy quantum firm Classiq for about $2.3 billion, Bloomberg News reports

Intel agreed to acquire Israeli quantum software company Classiq for about $2.3 billion, Bloomberg reported, citing people familiar with the matter. Intel announced the deal Monday without disclosing financial terms. Both companies declined to comment, and Reuters could not independently verify the report.

Published:

Updated:

What happened

Intel agreed to acquire Israeli quantum software company Classiq for about $2.3 billion, Bloomberg reported, citing people familiar with the matter. Intel announced the deal Monday without disclosing financial terms. Both companies declined to comment, and Reuters could not independently verify the report.

Confirmed

Global impact / market context

The deal would let Intel offer both quantum hardware and software, making it a full-stack provider, which means one supplier covers the whole system. Classiq's software simplifies writing quantum programs, and the startup would add quantum processors to Intel's existing chip lineup.

Analyst inference

Intel is positioning itself in quantum computing while continuing to sell central processing units and graphics processors. The reported price signals a large bet on software that works across many hardware makers, since Intel said Classiq's software would stay compatible with rivals' hardware.

Analyst inference

What to watch

  1. The deal needs regulatory approvals and is expected to close in the first half of 2027, a long timeline that gives regulators time to review competition and national security concerns. Confirmed
  2. Intel's capital spending, meaning cash put into new businesses, could rise as it builds quantum processors. Watch whether it funds this by cutting other budgets, borrowing money, or using cash available. Analyst inference
  3. Watch whether Intel discloses the actual purchase price and how it pays, since the $2.3 billion figure comes from unnamed sources and remains unconfirmed by either company. Proposed

Evidence

  • Original source link unavailable